IIM
VRTX icon

INTECH Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

INTECH Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
20,520
+807
+4% +$358K 0.09% 192
2026
Q1 		$8.8M Sell
19,713
-8,817
-31% -$4.11M 0.09% 210
2025
Q4 		$12.9M Sell
28,530
-5,831
-17% -$2.51M 0.12% 142
2025
Q3 		$13.5M Buy
34,361
+16,873
+96% +$7.05M 0.12% 135
2025
Q2 		$7.79M Buy
17,488
+8,791
+101% +$4.05M 0.07% 237
2025
Q1 		$4.22M Sell
8,697
-15,953
-65% -$7.43M 0.04% 381
2024
Q4 		$9.93M Buy
24,650
+6,937
+39% +$3.22M 0.1% 169
2024
Q3 		$8.24M Sell
17,713
-1,489
-8% -$715K 0.09% 180
2024
Q2 		$9M Sell
19,202
-1,353
-7% -$587K 0.11% 164
2024
Q1 		$8.59M Buy
20,555
+10,624
+107% +$4.49M 0.12% 155
2023
Q4 		$4.04M Sell
9,931
-1,539
-13% -$569K 0.06% 260
2023
Q3 		$3.99M Sell
11,470
-17,156
-60% -$6M 0.06% 266
2023
Q2 		$10.1M Sell
28,626
-12,492
-30% -$4.21M 0.1% 209
2023
Q1 		$13M Buy
41,118
+12,631
+44% +$3.79M 0.1% 248
2022
Q4 		$8.23M Buy
28,487
+5,843
+26% +$1.78M 0.06% 318
2022
Q3 		$6.56M Buy
22,644
+15,771
+229% +$4.54M 0.05% 331
2022
Q2 		$1.94M Buy
+6,873
New +$1.84M 0.01% 456

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

INTECH Investment Management's VRTX Position: Q2 2026 in Review

INTECH Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 4.1% in Q2 2026, buying an estimated $358K and bringing the position to 20,520 shares worth $10.2M. The position accounts for 0.09% of the portfolio, ranked #192.

INTECH Investment Management first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $13.5M in Q3 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • INTECH Investment Management held 20,520 shares of Vertex Pharmaceuticals worth $10.2M as of Q2 2026.
  • INTECH Investment Management bought 807 Vertex Pharmaceuticals shares in Q2 2026, an estimated $358K.
  • Vertex Pharmaceuticals made up 0.09% of INTECH Investment Management's portfolio in Q2 2026, its #192 holding.
  • INTECH Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's Vertex Pharmaceuticals position peaked at $13.5M in Q3 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.